IS5220A - Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum - Google Patents

Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Info

Publication number: IS5220A
Authority: IS; Iceland
Prior art keywords: carprofen; oxygenase; cyclo; dogs; inflammation
Prior art date: 1997-05-05

Application number

IS5220A

Other languages

English (en)

Inventor

Marie Lundy Kristin

Paul Ricketts Anthony

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1999-10-19

Publication date

1999-10-19

1999-10-19 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1999-10-19 Publication of IS5220A publication Critical patent/IS5220A/is

Links

241000282472 Canis lupus familiaris Species 0.000 title 1
102000010907 Cyclooxygenase 2 Human genes 0.000 title 1
108010037462 Cyclooxygenase 2 Proteins 0.000 title 1
206010061218 Inflammation Diseases 0.000 title 1
IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 title 1
229960003184 carprofen Drugs 0.000 title 1
230000004054 inflammatory process Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

IS5220A 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum IS5220A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en)	1997-05-05	1998-05-01	Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number	Publication Date
IS5220A true IS5220A (is)	1999-10-19

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5220A IS5220A (is)	1997-05-05	1999-10-19	Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (is)
JP (1)	JP2000513020A (is)
KR (2)	KR20040004406A (is)
CN (1)	CN1255059A (is)
AP (1)	AP9801234A0 (is)
AR (2)	AR011726A1 (is)
AU (1)	AU6932198A (is)
BG (1)	BG103852A (is)
BR (1)	BR9808720A (is)
CA (1)	CA2288759A1 (is)
DZ (1)	DZ2479A1 (is)
EA (1)	EA003696B1 (is)
GT (1)	GT199800063A (is)
HR (1)	HRP980244A2 (is)
HU (1)	HUP0001286A3 (is)
ID (1)	ID21311A (is)
IL (1)	IL132570A0 (is)
IS (1)	IS5220A (is)
MA (1)	MA26491A1 (is)
NO (1)	NO995389L (is)
NZ (1)	NZ500183A (is)
OA (1)	OA11213A (is)
PA (1)	PA8450601A1 (is)
PE (1)	PE72599A1 (is)
PL (1)	PL337003A1 (is)
SK (1)	SK148199A3 (is)
TN (1)	TNSN98059A1 (is)
TW (1)	TW590773B (is)
UY (1)	UY24989A1 (is)
WO (1)	WO1998050033A1 (is)
YU (1)	YU55899A (is)
ZA (1)	ZA983722B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en)	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) *	1998-10-23	2000-05-04	Merck Frosst Canada & Co.	Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
DE60023119T2 (de) *	1999-03-10	2006-07-20	G.D. Searle Llc	Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
WO2001034204A1 (en) *	1999-11-11	2001-05-17	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) *	2000-05-15	2004-07-22	メルクフロストカナダアンドカンパニー	Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
ATE511844T1 (de)	2000-06-13	2011-06-15	Wyeth Llc	Analgetische und entzündungshemmende zusammensetzungen enthaltend celecoxib und ibuprofen
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
CA2422803A1 (en)	2000-08-07	2002-02-14	Vanderbilt University	Detection of cox-2 activity and anandamide metabolites
WO2003007875A2 (en) *	2001-07-16	2003-01-30	Hoegestaett Edward	Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ATE342722T1 (de)	2003-05-07	2006-11-15	Osteologix As	Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
CN1829510A (zh) *	2003-07-31	2006-09-06	法马西亚和厄普乔恩公司	抗炎剂的可分散性制剂
KR20080003429A (ko) *	2005-05-20	2008-01-07	화이자 리미티드	비스테로이드 소염 약물 및 알파-델타-리간드의 상승작용적조합물
WO2008122965A2 (en)	2007-04-04	2008-10-16	Sigmoid Pharma Limited	Pharmaceutical cyclosporin compositions
EP2061587A1 (en)	2007-04-26	2009-05-27	Sigmoid Pharma Limited	Manufacture of multiple minicapsules
ES2530049T3 (es)	2009-05-18	2015-02-26	Sigmoid Pharma Limited	Composición que comprende gotas de aceite
EP2464341B1 (en)	2009-08-12	2022-07-06	Sublimity Therapeutics Limited	Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
WO2015134792A1 (en)	2014-03-06	2015-09-11	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
HUE053624T2 (hu)	2014-11-07	2021-07-28	Sublimity Therapeutics Ltd	Ciklosporint tartalmazó készítmények
MX2017009011A (es) *	2015-01-09	2017-10-02	Jaguar Animal Health	Metodos para tratar la diarrea en animales de compañia.
EP4125874A4 (en) *	2020-03-25	2024-05-01	SRI International	LIPOXYGENASE INHIBITORS
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Ceased
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Ceased
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Ceased
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
AU6932198A (en)	1998-11-27
IL132570A0 (en)	2001-03-19
MA26491A1 (fr)	2004-12-20
JP2000513020A (ja)	2000-10-03
ID21311A (id)	1999-05-20
YU55899A (sh)	2003-08-29
BG103852A (en)	2000-06-30
DZ2479A1 (fr)	2003-02-01
NO995389L (no)	2000-01-04
TNSN98059A1 (fr)	2005-03-15
AP9801234A0 (en)	1999-11-04
ZA983722B (en)	1999-11-04
PL337003A1 (en)	2000-07-31
HUP0001286A2 (hu)	2000-11-28
NO995389D0 (no)	1999-11-04
KR20040004406A (ko)	2004-01-13
GT199800063A (es)	1999-10-26
SK148199A3 (en)	2001-09-11
PE72599A1 (es)	1999-08-12
HRP980244A2 (en)	1999-02-28
UY24989A1 (es)	2001-10-25
AR011726A1 (es)	2000-08-30
OA11213A (en)	2003-07-14
BR9808720A (pt)	2000-07-11
KR20010012300A (ko)	2001-02-15
CN1255059A (zh)	2000-05-31
HUP0001286A3 (en)	2000-12-28
EA199900895A1 (ru)	2000-06-26
EP0988034A1 (en)	2000-03-29
NZ500183A (en)	2002-04-26
WO1998050033A1 (en)	1998-11-12
CA2288759A1 (en)	1998-11-12
TW590773B (en)	2004-06-11
AR039628A2 (es)	2005-03-02
PA8450601A1 (es)	2000-05-24
EA003696B1 (ru)	2003-08-28

Publication	Publication Date	Title
IS5220A (is)	1999-10-19	Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum
NO20005190L (no)	2000-11-30	Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no)	2001-09-19	Quinasoliner og terapautisk anvendelse derav
IS5405A (is)	2000-03-14	Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
DE69825447D1 (de)	2004-09-09	Gerät zur dermatologischen behandlung
IS2107B (is)	2006-05-15	Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
EE200100480A (et)	2002-12-16	Ksenoon kasutamiseks närvimürgistuste ravis
NO983576D0 (no)	1998-08-04	Brönnbehandlingsfluider og fremgangsmåter
NO20022656D0 (no)	2002-06-05	Caspaseinhibitorer og anvendelse derav
DE69911221D1 (de)	2003-10-16	Methode und gerät zur darreichung von therapeutischen mitteln in verbindung mit dem plazieren von radioaktiven körnern
IS5928A (is)	2001-04-27	Aðferðir og samsetningar til að hindra lyfjaþol
IS5504A (is)	2000-05-19	Samsetning virk við meðhöndlun á getuleysi
DE60019490D1 (de)	2005-05-25	Brennstofförder-und behandlungsvorrichtung
ID18741A (id)	1998-05-07	Zat nikotinat dalam terapi
DE69701250D1 (de)	2000-03-09	Tierbehandlungsvorrichtung
IS4628A (is)	1997-12-04	Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
NO20012738D0 (no)	2001-06-01	Terapeutiske produkter og anvendelse derav
IS5809A (is)	2001-01-12	Samtíma inngjöf ACAT og MMP tálma til meðhöndlunar á skemmdum vegna fituhrörnunar
ITMI20001555A0 (it)	2000-07-11	Procedimento e dispositivo di trattamento elettrochimico
DE69932577D1 (de)	2006-09-14	Stangenbehandlungsgerät und Stangenladegerät
DK0915655T3 (da)	2005-07-11	Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
IS6428A (is)	2002-06-19	Aðferð og blanda til að meðhöndla sársauka
IS5324A (is)	1999-12-28	(S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
IS5857A (is)	2001-02-23	Aðferð til flökunar á fiski og flökunarvél til notkunar við flökunina
ID28817A (id)	2001-07-05	Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri